196 related articles for article (PubMed ID: 12359981)
1. The Glu298Asp polymorphism of the NOS 3 gene as a determinant of the baseline production of nitric oxide.
Veldman BA; Spiering W; Doevendans PA; Vervoort G; Kroon AA; de Leeuw PW; Smits P
J Hypertens; 2002 Oct; 20(10):2023-7. PubMed ID: 12359981
[TBL] [Abstract][Full Text] [Related]
2. Glu298Asp eNOS gene polymorphism causes attenuation in nonexercising muscle vasodilatation.
Dias RG; Alves MJ; Pereira AC; Rondon MU; Dos Santos MR; Krieger JE; Krieger MH; Negrão CE
Physiol Genomics; 2009 Apr; 37(2):99-107. PubMed ID: 19158254
[TBL] [Abstract][Full Text] [Related]
3. Does lipoprotein(a) impair endothelial function?
Schlaich MP; John S; Langenfeld MR; Lackner KJ; Schmitz G; Schmieder RE
J Am Coll Cardiol; 1998 Feb; 31(2):359-65. PubMed ID: 9462580
[TBL] [Abstract][Full Text] [Related]
4. Functional gene testing of the Glu298Asp polymorphism of the endothelial NO synthase.
Schneider MP; Erdmann J; Delles C; Fleck E; Regitz-Zagrosek V; Schmieder RE
J Hypertens; 2000 Dec; 18(12):1767-73. PubMed ID: 11132600
[TBL] [Abstract][Full Text] [Related]
5. The effect of arginine vasopressin on endothelin production in the human forearm vascular bed.
Postma CT; Maessen SM; Thien T; Smits P
Neth J Med; 2005 Jun; 63(6):199-204. PubMed ID: 16011011
[TBL] [Abstract][Full Text] [Related]
6. Insulin modulation of an endothelial nitric oxide component present in the alpha2- and beta-adrenergic responses in human forearm.
Lembo G; Iaccarino G; Vecchione C; Barbato E; Izzo R; Fontana D; Trimarco B
J Clin Invest; 1997 Oct; 100(8):2007-14. PubMed ID: 9329964
[TBL] [Abstract][Full Text] [Related]
7. Endothelial release of nitric oxide contributes to the vasodilator effect of adenosine in humans.
Smits P; Williams SB; Lipson DE; Banitt P; Rongen GA; Creager MA
Circulation; 1995 Oct; 92(8):2135-41. PubMed ID: 7554193
[TBL] [Abstract][Full Text] [Related]
8. Forearm blood flow responses to a nitric oxide synthase inhibitor in patients with treated essential hypertension.
Calver A; Collier J; Vallance P
Cardiovasc Res; 1994 Nov; 28(11):1720-5. PubMed ID: 7531114
[TBL] [Abstract][Full Text] [Related]
9. Impaired nitric oxide-mediated vasodilatation and total body nitric oxide production in healthy old age.
Lyons D; Roy S; Patel M; Benjamin N; Swift CG
Clin Sci (Lond); 1997 Dec; 93(6):519-25. PubMed ID: 9497788
[TBL] [Abstract][Full Text] [Related]
10. Effects of arginine vasopressin and 1-desamino-8-D arginine vasopressin on forearm vasculature of healthy subjects and patients with a V2 receptor defect.
van Lieburg AF; Knoers NV; Monnens LA; Smits P
J Hypertens; 1995 Dec; 13(12 Pt 2):1695-700. PubMed ID: 8903635
[TBL] [Abstract][Full Text] [Related]
11. Lack of association of the Glu298Asp polymorphism of endothelial nitric oxide synthase with manifest coronary artery disease, carotid atherosclerosis and forearm vascular reactivity in two Austrian populations.
Schmoelzer I; Renner W; Paulweber B; Malaimare L; Iglseder B; Schmid P; Schallmoser K; Wascher TC
Eur J Clin Invest; 2003 Mar; 33(3):191-8. PubMed ID: 12641536
[TBL] [Abstract][Full Text] [Related]
12. Haemodynamic and sympathetic effects of inhibition of nitric oxide synthase by systemic infusion of N(G)-monomethyl-L-arginine into humans are dose dependent.
Lepori M; Sartori C; Trueb L; Owlya R; Nicod P; Scherrer U
J Hypertens; 1998 Apr; 16(4):519-23. PubMed ID: 9797197
[TBL] [Abstract][Full Text] [Related]
13. Effect of local intra-arterial NG-monomethyl-L-arginine in patients with hypertension: the nitric oxide dilator mechanism appears abnormal.
Calver A; Collier J; Moncada S; Vallance P
J Hypertens; 1992 Sep; 10(9):1025-31. PubMed ID: 1328361
[TBL] [Abstract][Full Text] [Related]
14. The contribution of nitric oxide to exercise hyperemia in the human forearm.
Gordon MB; Jain R; Beckman JA; Creager MA
Vasc Med; 2002 Aug; 7(3):163-8. PubMed ID: 12553738
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of nitric oxide synthesis in the forearm arterial bed of patients with advanced cirrhosis.
Campillo B; Chabrier PE; Pelle G; Sediame S; Atlan G; Fouet P; Adnot S
Hepatology; 1995 Nov; 22(5):1423-9. PubMed ID: 7590658
[TBL] [Abstract][Full Text] [Related]
16. Forearm vasoconstriction in response to noradrenaline and NG-monomethyl-L-arginine in essential hypertension.
Kneale BJ; Chowienczyk PJ; Brett SE; Cockcroft JR; Ritter JM
Clin Sci (Lond); 1999 Sep; 97(3):277-82. PubMed ID: 10464052
[TBL] [Abstract][Full Text] [Related]
17. The T-786C and Glu298Asp polymorphisms of the endothelial nitric oxide gene affect the forearm blood flow responses of Caucasian hypertensive patients.
Rossi GP; Taddei S; Virdis A; Cavallin M; Ghiadoni L; Favilla S; Versari D; Sudano I; Pessina AC; Salvetti A
J Am Coll Cardiol; 2003 Mar; 41(6):938-45. PubMed ID: 12651037
[TBL] [Abstract][Full Text] [Related]
18. Comparison of forearm vasodilatation to substance P and acetylcholine: contribution of nitric oxide.
Newby DE; Boon NA; Webb DJ
Clin Sci (Lond); 1997 Feb; 92(2):133-8. PubMed ID: 9059313
[TBL] [Abstract][Full Text] [Related]
19. Flow-mediated nitric oxide activity in the forearm vasculature of premenopausal women.
Anumba DO; Robson SC; Ford GA
Br J Clin Pharmacol; 2002 Mar; 53(3):332-6. PubMed ID: 11874398
[TBL] [Abstract][Full Text] [Related]
20. Is nitric oxide involved in cutaneous vasodilation during body heating in humans?
Dietz NM; Rivera JM; Warner DO; Joyner MJ
J Appl Physiol (1985); 1994 May; 76(5):2047-53. PubMed ID: 7520431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
